Article Information
History
- March 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Juveriya Qamar Khan1,†,
- Megha Rohamare1,†,
- Karthic Rajamanickam2,
- Kalpana K Bhanumathy2,
- Jocelyne Lew3,
- Anil Kumar1,
- Darryl Falzarano3,4,
- Franco J Vizeacoumar2,5 and
- Joyce A Wilson1,*
- 1Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada
- 2Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada
- 3Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada
- 4Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK S7N 5B4 Canada
- 5Cancer Research Department, Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada
- ↵*Correspondence to Joyce Wilson (joyce.wilson{at}usask.ca)
↵† Juveriya Qamar Khan and Megha Rohamare contributed equally to this paper.
Posted March 09, 2023.
Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathology
